IP-10, MIP1α, IL-6, and IL-1β as Biomarkers Associated with Disease Severity of COVID-19
Open Access
- 9 June 2024
- journal article
- research article
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17 (5)
Abstract
Background: The factors responsible for the progression of COVID-19 from a mild illness to a severe and often lethal condition, characterized by respiratory failure and multiple organ involvement, remain unclear. The identification of biomarkers capable of predicting disease progression is of the highest importance. Objectives: This study sought to assess laboratory measurements of interferon-gamma inducible protein-10 (IP-10), macrophage inflammatory protein 1-alpha (MIP1α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) to achieve this objective. Methods: We measured IP-10 and MIP1α by qRT-PCR and IL-6 and IL-1β using an enzyme-linked immunosorbent assay in 120 serum samples. We analyzed differences between patients with moderate, severe, and recovered COVID-19. Results: The number of positive cases for biomarkers IP-10, MIP1α, IL-6, and IL-1β were significantly different between groups. The expression levels of IP-10 and MIP1α were significantly higher in patients with severe COVID-19 compared to those who had recovered. A strong positive association was observed between IP-10 and MIP1α in severe infection cases. Additionally, these biomarkers were relatively independent predictors of disease severity. Conclusions: The results suggest that IP-10, MIP1α, IL-6, and IL-1β are promising research candidates for understanding the severity of COVID-19 and for investigating possible pathophysiological mechanisms of the disease.Keywords
This publication has 45 references indexed in Scilit:
- Obesity: A potential risk factor for infection and mortality in the current COVID-19 epidemicDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19Cell, 2020
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019Chest, 2020
- Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine StormJournal of Clinical Immunology, 2020
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor systemCytokine & Growth Factor Reviews, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patientsEBioMedicine, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19Clinical & Translational Immunology, 2020